Atrys Health SA (ATRY) Stock Price & News

ATRY:BME

Atrys Health SA

€2.53

+2.22%

(+0.055) 1D

Sep 10, 5:36:00 PM GMT+2 · EUR

All symbols

YTD

MAX

	Symbol	Price	Change	% Change

Last report

Sep 10, 2026

Fiscal period

Q2 2026

EPS / Est. (EUR)

-€0.04 / -

0.00%miss

Revenue / Est. (EUR)

78.62M / 39.50M

+99.05%beat

Fiscal Q2 2026 earnings call

Waiting for the earnings call

At a glance

Insights from the latest news and reports

Previous reportsAll values in EUR

Loading Previous Earnings...

All values in EUR	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Revenue	58.75M	58.75M	13.40M	13.40M
Cost of goods sold	45.16M	45.16M	14.53M	14.53M
Cost of revenue	45.16M	45.16M	14.53M	14.53M
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	447.50K	447.50K	-83.00K	-83.00K
Operating expense	13.19M	13.19M	4.47M	4.47M
Total operating expenses	58.35M	58.35M	19.00M	19.00M
Operating income	400.50K	400.50K	-5.60M	-5.60M
Other non operating income	114.00K	114.00K	2.52M	2.52M
EBT including unusual items	-4.85M	-4.85M	-23.25M	-23.25M
EBT excluding unusual items	-4.87M	-4.87M	-6.87M	-6.87M
Income tax expense	-164.50K	-164.50K	-123.50K	-123.50K
Effective tax rate	3.39%	3.39%	0.53%	0.53%
Other operating expenses	5.51M	5.51M	1.96M	1.96M
Net income	-4.64M	-4.64M	-45.50M	-45.50M
Net profit margin	-7.91%	-7.91%	-339.45%	-339.45%
Earnings per share	-	-	-	-
Interest and investment income	38.00K	38.00K	261.00K	261.00K
Interest expense	-5.28M	-5.28M	-4.23M	-4.23M
Net interest expenses	-5.24M	-5.24M	-3.97M	-3.97M
Depreciation and amortization charges	7.23M	7.23M	2.60M	2.60M
EBITDA	4.73M	4.73M	-1.59M	-1.59M
Gain or loss from assets sale	-	-	-	-

Finance